Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Ipsos
  6. News
  7. Summary
    IPS   FR0000073298

IPSOS

(IPS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ipsos : phRMA - Growing trend, Increased vaccine confidence

01/29/2021 | 06:02am EDT

According to researchers writing in The Lancet, we need a majority of Americans to have the confidence to get vaccinated for COVID-19 if we are going to be effective in moving the United States toward population-level control of viral spread.

As Dr. Anthony Fauci has noted, 'If you have a vaccine that is highly effective and not enough people get vaccinated, you're not going to realize the full, important effect of having a vaccine.'

The good news is a growing majority of Americans are expressing COVID-19 vaccine readiness. The increase in confidence follows news about the first two COVID-19 vaccines confirmed with over 95% efficacy and the subsequent emergency use authorizations (EUA) granted by the U.S. Food and Drug Administration (FDA) for administration of the vaccines to patients.

Recent opinion research conducted by PhRMA[1], Gallup, Ipsos and others confirms this trend, with almost two-thirds of the U.S. public expressing willingness to get a vaccine if one were available to them today. Our most recent tracking survey, conducted with Morning Consult, shows 65% readiness for a vaccine, a 5-point increase from October. Gallup reports the same percentage and Ipsos shows an 8-point confidence boost of late, with 60% overall readiness. The PhRMA poll noted above also shows an 18-point increase in the number of Americans who say they will take a vaccine 'right away' (45%, up from 27%).

Another big story in Gallup's vaccine confidence numbers is the recent change by key subgroups. We have long seen significant differences in attitudes by gender, race, income, education and political party affiliation. Notably, the confidence gap has widened between Democrats (83%, up 8 points since December) and Republicans (45%, down 5 points), as well as between those with a 4-year college degree (77%, up 9 points) and those without (60%, down 1 point). The gender and race gaps, however, have closed over the past month to single digits (3 points and 5 points, respectively).

In line with these numbers is a growing appreciation for the significant value COVID-19 vaccines provide. In our survey noted above, 72% of American voters agree (39% strongly) that vaccines are key to ending the pandemic, and the public widely recognizes that vaccines will not only help save lives (62% likely to happen after a vaccination becomes available) but also restore core aspects of our day-to-day living, including the re-opening of schools (62% likely), businesses (61% likely) and restaurants (58% likely). Recent public polling reinforces theses trend with the Axios-Ipsos Coronavirus Index showing new urgency in plans to be vaccinated, and Pew Research linking intent to be vaccinated to confidence in biopharmaceutical research and development (R&D).

As the biopharmaceutical industry continues to study new and ongoing vaccine candidates through clinical trials, continued education will be critical to recognizing the benefits of the vaccines. We also know there continues to be several important questions from the public about these vaccines. It is critical all health care stakeholders come together to share open, honest and transparent information to help instill confidence.

Contact:

Tel: (202) 835-3400

Web: www.PhRMA.org

(C) 2021 Electronic News Publishing, source ENP Newswire

All news about IPSOS
06/08Peru's Leftist Candidate Leads Tight Presidential Vote
DJ
06/07Fujimori in lead in first official Peruvian presidential vote results
RE
06/06SOCIALIST CASTILLO LEADS PERUVIAN PR : Ipsos peru
RE
06/06FUJIMORI HAS 50.3% AND CASTILLO HAS : +/-3% error margin - peru ipsos exit poll
RE
06/06Conservative keiko fujimori leads socalist pedro castillo in peru presidentia..
RE
05/31India's Covid-19 Surge to Hamper Economic Recovery
DJ
05/27PRESS RELEASE : ABOUT YOU Holding AG: ABOUT YOU -3-
DJ
05/17SURVEY : Generation Z and Millennials Lead the Way as Financial Progress, Securi..
AQ
05/17BMO SURVEY : Canadians Lag Americans on Perceptions of Financial Progress but St..
AQ
05/11UBS Notes Peru's Second Round Presidential Race Tightens
MT
More news
Financials
Sales 2021 2 009 M 2 433 M 2 433 M
Net income 2021 136 M 165 M 165 M
Net Debt 2021 434 M 526 M 526 M
P/E ratio 2021 11,2x
Yield 2021 2,90%
Capitalization 1 511 M 1 828 M 1 830 M
EV / Sales 2021 0,97x
EV / Sales 2022 0,89x
Nbr of Employees 17 640
Free-Float 84,9%
Chart IPSOS
Duration : Period :
Ipsos Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IPSOS
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 40,29 €
Last Close Price 34,30 €
Spread / Highest target 22,4%
Spread / Average Target 17,5%
Spread / Lowest Target 10,8%
EPS Revisions
Managers and Directors
NameTitle
Didier Michel Truchot Chairman, President & Chief Executive Officer
Laurence Stoclet Chief Financial Officer, Director & Deputy CEO
Neville Rademeyer Global Chief Information Officer
Patrick Artus Independent Director
Dupont-Madinier Mary Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IPSOS24.28%1 828
OMNICOM GROUP INC.34.38%18 026
WPP PLC24.43%16 795
PUBLICIS GROUPE SA37.14%16 617
THE INTERPUBLIC GROUP OF COMPANIES, INC.45.24%13 438
WEIBO CORPORATION18.79%11 094